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INTRODUCTION
“For all the happiness Mankind can gain is not in pleasure but in rest from pain “
JOHN DRYDEN
Pain derived from the Latin word “poena” which means punishment. In ancient times, 
Pain was considered as punishment from god.
Labor is an extremely painful process. Being a natural process, women have accepted 
labor  pain  as  a  normal  one.  Traditionally  a  number  of  techniques  have  been  employed to 
provide  labor  analgesia.  Epidural  analgesia,  either  continuous  or  intermittent  boluses,  is 
considered  to  be  the  gold  standard  in  labor  analgesia  due  to  the  long  duration  of  labor. 
Traditionally only high doses of local anaesthetics were used. Though they provide excellent 
pain  relief,  they  produce an unacceptable  high  level  of  motor  blockade  which impairs  the 
parturient’s ability to bear down during labor, resulting in prolonged labor. Lower doses of 
local anaesthetics by themselves are inadequate. The technique of spinal analgesia in labor pain 
relief was a setback due to the shorter duration of analgesia. The newer technique of combined 
spinal-epidural analgesia is a major breakthrough in labor analgesia.
Current  obstetric  practice  aiming  to  provide  effective  pain  relief,  led  Collins  and 
colleagues  to  popularize  the  combined spinal-epidural  technique for  labor  analgesia.  These 
techniques  involved  an  initial  intrathecal  injection  of  a  local  anaesthetic  with  an  opioid 
(Fentanyl) to establish analgesia and subsequent epidural injections to maintain analgesia. The 
doses of drugs involved were such that ambulation was possible. 
The discovery of  opioid receptors  in spinal  analgesia provides an interesting option. 
Opioid agonists selectively block pain impulses but leave the motor system unaffected. The 
doses for central neuraxial blockade are also very little when compared to parenteral routes and 
does not result in significant respiratory depression both to the mother and the fetus. Since 
opioids and local anaesthetics act at different sites, their combination provides a synergistic 
effect  permitting  to  use  lesser  concentration  of  both.  When  used  in  such  low  doses  the 
individual side effects are minimized while maximizing the desired effects.
Ropivacaine, a  newer local anaesthetics which has been shown to cause less intense 
motor blockade and less cardiotoxic is rapidly evolving as local anaesthetic of choice in labor 
analgesia as well as in post operative analgesia. The aim of this study was to compare the 
analgesic and the motor sparing effect of low dose intrathecal Ropivacaine 3mg with or without 
sufentanil  10µg as a  part  of  CSE labor  analgesia.  Efficacy,  Duration of  analgesia,  sensory 
blockade and fetal effects were studied in detail.
AIM
To  compare  the  effect  of  low  dose  intrathecal  Ropivacaine   alone  with  Ropivacaine  and 
Sufentanil in providing labor analgesia.
The parameters that were analysed include:
- The analgesic and the motor sparing effect of low dose intrathecal Ropivacaine 
alone and with sufentanil in labor analgesia.
- Maternal and fetal outcomes.
- Safety and patient comfort.
HISTORY
Throughout history women suffered with pain until the advent of using ether for labor analgesia 
by Dr.James Young Simpson of Edinburgh on 19th January 1847, which opened up the interesting 
avenue of pain relief for labor. At that time it was a highly controversial issue. 
Labor analgesia became popular when John Snow administered chloroform anesthesia to Queen 
Victoria for the birth of her 8th child Prince Leopold in 1853 and 9th child Princess Beatrice in 1857. 
Kinkovich of St.Petersburg used Nitrous Oxide in Obstetric analgesia in 1880.Guedel designed an 
apparatus for the self-administration of nitrous oxide in labor in 1910.
Dennis Jackson and Striker used Trichloroethylene in 1934. Freedman inhaler was developed in 
1943 to facilitate administration of analgesic concentrations of Trichloroethylene to women in labor.
Methoxyflurane was used for labor in 1959 and in 1970. Even midwives were permitted to use 
0.35% Methoxyflurane.
Tunstall tried Entonox in 1962.Inhalation anesthesia for labor is not much used now except 
Entonox. Following the demonstration of spinal analgesia by August Bier in 1899 this was also tried 
for labor but without much success.
Stoeckel of Marburg described extradural sacral block in 1909 using Procaine. This was 
followed by Schlimpert and Schneider who used 50ml of 1% Procaine.
Eugen Bagden in 1930 and J.G.P.Clealand of University of Oregon in 1933 provided important 
contributions to the understanding of the anatomical pathways and physiology of labor pain. 
Fidel Pages of Spain performed the first lumbar epidural block in 1921 and Dogliotti of Turin 
developed the technique in 1930. Refinements in the needle by Tuohy and in the catheter quality made 
continuous epidural analgesia a popular technique. The flexibility introduced by the continuous 
epidural technique with regard to the duration was especially very suitable for labor because of the 
longer duration required for successful labor analgesia. The CSE technique combines the advantages of 
both spinal and epidural analgesia.
The discovery of opioid receptors in the central nervous system by Snyder in 1973 and Pert in 
1976 was soon followed by flurry of activity. A number of opioids have been used successfully both 
Intrathecally and extradurally. Highly lipophilic opioids like Fentanyl, Sufentanil and Alfentanil are 
more suitable than less lipophilic drugs like morphine. Opioids provide excellent pain relief when used 
Intrathecally or extradurally without affecting the motor system – a property that is much desired in an 
agent used for labor analgesia. 
ANATOMY OF THE EPIDURAL AND 
SUBARACHNOID   SPACE
THE EPIDURAL SPACE
The epidural (extradural, peridural) space is that part of the vertebral canal external to the 
duramater and its contents. It lies between the dura and the periosteum lining the canal, and 
corresponds to the very restricted space within the skull between the two layers of the cranial dura 
mater enclosing the venous sinuses.
BOUNDARIES
By vertebral bodies Anteriorly: and posterior longitudinal ligaments
Posteriorly: Vertebral arches and ligamentum flavum
Superiorly: Fusion of dura with periosteum at foramen magnum
Inferiorly: Sacrococcygeal ligament at sacral hiatus
The epidural space extends from the Foramen magnum to sacral hiatus. Except in the lower 
sacral region it is annular in shape, and narrow. The anterior and posterior nerve roots with their dural 
coverings pass across the very narrow space to unite in the intervertebral foramen to form the 
segmental nerves. The rest of the epidural space is occupied by numerous small veins and by fatty 
areolar tissue, which is continuous around the nerves through the intervertebral foramina with the fat in 
the paravertebral spaces. The upward spread of drugs is limited by the attachment of dura to the 
circumference of the foramen magnum.
The amount of fat in the areolar tissue of the space depends on the obesity of the subject. It is 
greatest in the median plane posteriorly where the summit of the vertebral arch is commonly separated 
from the rounded posterior aspect of the dura by approximately 5 to 6 mm, and antero-laterally where it 
is continuous with the pads of fat surrounding the spinal nerves in the intervertebral foramina. Between 
the postero-lateral walls of the lumbar vertebral canal and the dura, the space is narrower, and the fat 
less evident. Anteriorly in a thin subject, the space is only potential, since here the dura lies close to the 
posterior longitudinal ligament on the posterior aspect of the vertebral bodies.
The spread of the local analgesic solution injected into the epidural space is not accurately 
predictable, because of the resistance offered by the fatty areolar tissue and the numerous foramina 
through which the fluid can leak. A dorso-median fold of dura mater was demonstrated in a few cases, 
which sometimes divides the epidural space into a ventral and two dorso-lateral compartments, not 
necessarily freely communicating with each other. The median thickness of the space might be only 2 
mm. These observations explain the occasional patchy analgesia and inadvertent dural puncture when 
the midline approach is used.
The space occupied by the venous plexus varies with the amount of the venous distention and is 
related to the intrathoracic pressure.
SUBARACHNOID SPACE
The subarachnoid space is lined externally by the arachnoid, internally by the piamater, and 
innumerable cobweb like trabeculae run between the two membranes, though sparsely in the cisterns, 
the cranial and spinal nerves traverse it. It houses the main blood vessels of the central nervous system, 
and extends along the smaller arteries and capillaries in to the substance of the brain and the spinal 
cord. Here the cerebrospinal fluid takes the place of the tissue fluid (lymph) found in other regions of 
the body.
          In the cervical and thoracic regions the space is annular and the distance between the arachnoid 
and pia covering the cord, even in an adult is only about 3mm, so that a spinal tap here is fraught with 
the danger of injuring the cord with the needle. The cord commonly ends at the lower end of the first 
lumbar vertebra so that below this level the subarachnoid space is no longer annular but it is practically 
circular in section and has a diameter of about 15mm. Lumbar puncture should be carried out in the 
lower lumbar region. The fact that the cord terminates above this level renders it immune to injury, the 
constituent nerve roots of the cauda equina escape damage on account of their limited mobility, and the 
absence of the cord greatly increases the cross sectional area of the sub arachnoid space, the ultimate 
target at which the needle is aiming.  
PRESSURE AND VOLUMES OF THE EPIDURAL SPACE
Substantial differences have been observed between the actions of epidural and subarachnoid 
injections of local anesthetics in the pregnant and non-pregnant patient. In many respects the changes 
are thought to be due to the mechanical effects of the pregnancy as the actual size of the space available 
is reduced. The return of blood from the lower part of the body is mainly via the inferior vena cava; the 
epidural veins are also involved and they become dilated. This reduces the space available for the 
injection of fluid into the epidural space. For the same reason, the subarachnoid space is also reduced. 
As these veins are an alternate method of returning lower limb blood flow, their use is maximized if 
there is an obstruction to vena cava return as can happen in pregnancy.
There are three effects from this:
 The volume of local anaesthetic required to provide an extensive block is reduced in pregnancy.
 There is an increased risk of puncture of the distended veins by either the spinal or epidural 
needles or the catheter.
 Distension is likely to be maximum in the sitting position and pressure in the epidural space is 
also increased.
For the above reasons pressure in the epidural space is increased, particularly in the sitting 
position. During a contraction, as the blood expelled from the contracting uterus passes to the epidural 
venous plexus, the pressure in the epidural space may rise by 4-10 cms H2O. It is for this reason that 
injections of local anesthetics should be withheld during a contraction, as the spread may be 
unpredictable and probably excessive.
Although the engorgement of the epidural veins would appear to be increased in the sitting 
position, there is little evidence to suggest that the lateral position is associated with a decrease in 
complication rates such as dural puncture or reduced incidence of venous puncture.
PHYSIOLOGY OF PAIN IN LABOR
Pain as described by the International association for study of pain (IASP) is “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or as described in 
terms of such damage”.
PATHWAYS AND MECHANISM
Bonica has modified the description of peripheral pain pathways proposed by Cleland in 1993.
PAIN IN THE FIRST STAGE OF LABOR
Uterine contractions cause stretching, tearing and distortion and possibly ischemia of the uterine 
tissues, whilst simultaneously dilating the cervix and stretching the lower uterine segment. The 
intensity of the pain increases progressively with the raising strength of the contractions. In early labor 
only the nerve roots of T11 and T12 are involved, but as the intensity of contractions increases, T10 
and L1 are recruited.
Backache is a frequent complaint during labor and may be caused by two mechanisms. Pain 
originating in the uterus or cervix may be referred to the cutaneous branches of the posterior divisions 
of T10-L1. Pressure on peri uterine tissues often, in association with fetal malposition or an unusual 
shape of the sacrum, refer to the L5-S1 segments.
PAIN IN THE SECOND STAGE OF LABOR
The pain caused by the distension of the pelvic structure and perineum following descent of the 
presenting part is added to the pain of uterine contractions, although once cervical dilatation is 
complete the pain induced by uterine contractions may become less severe. The uterine pain continues 
to be referred to T10-L1, while the pain produced by stretching or pressure exerted on intrapelvic 
structures, including the peritoneum, bladder, urethra and rectum is referred to sacral segments. 
Pressure on the roots of the lumbosacral plexus may manifest itself, as pain felt low in the back or in 
the thighs. Pain produced by stretching of the perineum is transmitted by the pudendal nerve (S2, 3, 4) 
and in part by the posterior cutaneous nerve of the thigh (S2, 3), the genitofemoral nerve (L1, 2) and 
the ilio-inguinal nerve (L1).
CLINICAL IMPLICATIONS
During the first stage of labor, a block limited to the T11-T12 segments at the beginning and 
later extending to involve T10 and L1 will usually be sufficient to provide excellent pain relief whilst 
avoiding neural blockade of the sacral segments. Premature sacral blockade can result in the loss of the 
stimulating effect upon contractions of Ferguson’s reflex and the loss of pelvic muscle tone, which aids 
the rotation of the presenting part.
Later in the first stage and during the early part of the second stage, pain is often experienced in 
lower lumbar and upper sacral segments, so that the block will have to be extended if analgesia is to be 
guaranteed.
Complete block of the sacral segments need to be performed only when perineal pain becomes 
established.
Epidural block will interrupt the preganglionic sympathetic fibers and leave the postganglionic 
fibers intact.
RELAY OF PAIN
Pain from the peripheral nociceptive field is transmitted to the cortex by the afferents arising 
from the dorsal root ganglion i.e., the first order neurons. The majorities of these first order neurons 
passes to the contralateral side as the spinothalamic tract and gives afferents to the medullar centre, 
reticular activating system, and hypothalamus and reach the post central gyrus in the cortex. The 
efferent impulses reach the segmental area through the corticospinal and rubrospinal tracts.
Some of the first order neurons communicate through the intern uncial neurons and give 
efferent impulses to the peripheral nociceptive areas from the segmental autonomic reflexes.
Labor and vaginal delivery produces tissue damage, and like tissue injury from any cause, result 
in pain and local segmental, suprasegmental and cortical responses.
Pain relief during labor provides excellent satisfaction for the mother in labor. Lumbar epidural 
analgesia is far superior to parenteral and inhalational approaches, as the mother remains alert 
throughout and the analgesia can be extended to relieve both uterine pain and pain related to distension 
of the lower birth canal, thus providing analgesia for instrumental delivery or caesarean sections if 
there is any indication. Regional analgesia minimizes or completely avoids the problems of maternal 
aspiration, as well as neonatal drug depression due to general anesthesia.
CONSEQUENCES OF PAIN IN LABOR
Pain is a noxious and unpleasant stimulus, which produces fear and anxiety. It was once thought 
that fear, anxiety and ignorance exacerbated labor pain. But the opposite may also be true.
The maternal and fetal consequences of unrelieved pain in labor has been stressed on many an 
occasion. Unrelieved pain in labor causes increased plasma cortisol and catecholamine levels. This may 
be responsible for the decrease in the utero-placental blood flow. Effective pain relief reduces plasma 
noradrenalin levels, prevents the rise of 11-hydroxycorticosteroid in the first and second stages. It also 
prevents metabolic acidosis by reducing the rate of rise of lactate, pyruvate and decreases maternal 
oxygen consumption by up to 14%. Effective epidural analgesia prevents the pain induced 
hyperventilation and hypocapnia, which can be severe enough to produce tetany in painful labor. The 
respiratory alkalosis further impairs feto-maternal gas exchange by shifting the oxygen dissociation 
curve to the left and the fall of fetal PaO2.
PHYSIOLOGICAL CONSIDERATIONS DURING LABOR
RESPIRATORY SYSTEM
During labor, particularly in the late first stage and second stage, the pain from episodic uterine 
contractions produce corresponding increases in maternal minute ventilation (as much as 300% over 
that of non pregnant women) and oxygen consumption. Maternal hypocarbia (PaCO2 <=20mmHg) and 
alkalemia (pH 7.55) results. Hypocarbia can lead to hypoventilation between uterine contractions, 
resulting in intermittent hypoxemia (particularly in obese patients or those who have received 
parenteral opioids). Epidural analgesia eliminates these pain-induced increases in oxygen consumption 
and minute ventilation and the accompanying hyperventilation-hypoventilation cycle. Pain, which 
causes the pregnant woman to hyperventilate, shifts the oxygen dissociation curve to the left. This 
increases the maternal oxygen affinity and makes the unloading of oxygen to the fetus less favorable.
During pregnancy, capillary engorgement of the mucosa occurs throughout the respiratory tract, 
potentially causing edema in the nasopharynx, oropharynx, larynx and trachea. Therefore, manipulation 
of the upper airway requires extreme care. Regional analgesia abolishes the requirement of airway 
manipulation and hence avoids the dangers involved in general anesthesia.
CARDIOVASCULAR CHANGES
The cardiovascular system is progressively stressed during pregnancy and parturition. Many of 
the changes appear during the first trimester of pregnancy (increases in cardiac output of 22% and 
decrease in systemic vascular resistance by 30% at 8 weeks gestation). The changes continue into the 
second and early third trimester of pregnancy, when cardiac output increases to approximately 30-40% 
of non-pregnant values. The increase in cardiac output during pregnancy is primarily a result of 
increase in stroke volume (by about 30%) with a more modest increase in heart rate (10-15 beats/min). 
Arterial blood pressure does not change during normal pregnancy because of a decrease in peripheral 
vascular resistance.
Clinical examination of a pregnant woman may reveal a wide, loud split first sound and a soft 
ejection systolic murmur, caused by the increased blood flow and vasodilatation. The elevated 
diaphragm usually alters the position of the heart at term, so that the point of maximum impulse is felt a 
little to the left. The axis on the ECG is also shifted to left. ECG may show non-specific ST, T and Q 
wave changes and benign arrhythmias.
The pain and apprehension of labor adds to cardiac work during pregnancy and increases stroke 
volume and cardiac output by 45% over prelabor values. Blood pressure increases during painful labor. 
Additional stresses are imposed by uterine contractions, which cause, in effect an auto transfusion. 
With each uterine contraction, blood from the body of the uterus is pushed into the central circulation 
and blood volume and cardiac output increase by 10-25%. After delivery also the same auto transfusion 
occurs. In addition to increase in central blood volume, obstruction of the venacava is relieved. As a 
result there is a marked increase (up to 80% of pre labor values) in stroke volume and cardiac output in 
the immediate post partum. Patients with limited cardiac reserve may experience cardiac failure at this 
time.
Despite the increase in blood volume and cardiac output, the parturient at term is susceptible to 
hypotension in supine position. When the patient is supine, the gravid uterus partially or completely 
compresses the aorta and inferior vena cava, leading to decreased venous return, decreased cardiac 
output, hypotension and reduced uterine blood flow. Up to 10% of pregnant patients near term develop 
signs of shock (hypotension, pallor, sweating, nausea, vomiting, changes in cerebration) when they 
assume this position. 
Compensatory mechanisms include increased sympathetic tone and collateral routes 
(paravertebral veins to azygos vein) to improve venous return during obstruction of the vena cava. 
Caval compression also increases uterine venous back pressure, which further decreases uterine blood 
flow. Compression of the aorta is not associated with maternal symptoms but does cause arterial 
hypotension in the lower extremities and uterine arteries, which can further decrease uterine blood flow 
and impair utero-placental perfusion.
 During labor the patient should be positioned either on her side or with a left tilt. During 
delivery the operating or the delivery table can be tilted laterally to the left or a small pillow or foam 
rubber wedge can be used to elevate the patient’s right buttock and back to about 10-15 cms.
The pregnant woman at term is in a hypercoagulable state owing to increase in factors VII, VIII, 
X and plasma fibrinogen. Estimation of blood loss at delivery varies but may be around 500ml for an 
uncomplicated vaginal delivery. Blood loss during caesarean section varies widely with 500 to 1400 
ml, being reported.
HEPATIC CHANGES
Total protein concentration and the albumin- globulin concentration ratio decrease. Although 
plasma cholinesterase activity is reduced during pregnancy and in the immediate post partum period, 
moderate doses of Succinylcholine are usually metabolized easily.
GASTRO INTESTINAL CHANGES
During pregnancy, the secretion of gastric acid increases. During late pregnancy, gastric 
emptying is slowed as a result of displacement of pylorus by the enlarged uterus. Pain, anxiety and use 
of opioid analgesia during labor contribute to impaired gastric emptying. Intra-gastric pressure is 
increased and lower esophageal sphincter tone is decreased during pregnancy. All these changes 
increase the risk of regurgitation and aspiration during either during general anaesthesia or during the 
state of impaired consciousness from any other cause.
CENTRAL NERVOUS SYSTEM CHANGES
Pregnancy reduces anesthetic requirements both during regional and general anesthesia. During 
spinal or epidural anesthesia, less local anesthetic is required to produce a given level of anesthesia. 
This was thought to be due to the mechanical effects of increased intra-abdominal pressure, causing 
epidural venous engorgement and a reduction of both the epidural and subarachnoid spaces. Reduced 
MAC is seen during early pregnancy and immediate post partum period.
RENAL CHANGES
Renal blood flow and glomerular filtration rate increase rapidly during pregnancy, reflecting 
changes in cardiac output. During the third trimester, they slowly return to normal. Creatinine clearance 
usually increases and therefore the upper limits of normal for blood urea nitrogen and serum creatinine 
are lower in the pregnant woman.
UTERINE BLOOD FLOW
Uterine blood flow in the parturient at term is approximately 700ml/min and is determined by 
the following relationship:
Uterine blood flow = (uterine arterial pressure) - (uterine venous pressure)
          (Uterine vascular resistance)
There is auto regulation of uterine blood flow. The vessels are maximally dilated during 
pregnancy. As such in the absence of aortic compression, uterine arterial pressure directly reflects 
maternal blood pressure and cardiac output. Uterine blood flow decreases during maternal hypotension 
(sympathetic block, hypovolemia, hemorrhage, compression of the inferior vena cava), in 
circumstances in which uterine venous pressure is increased (compression of the inferior venacava, 
abruption placenta), and with increases in uterine vascular resistance (maternal hypertensive disorders, 
α agonists, uterine hypercontracitility). Due to increased maternal mean arterial pressure and a 
concomitant decrease in uterine blood flow there are deleterious effects on the fetus. 
After epidural analgesia uterine blood flow increases, mean arterial pressure stabilizes and 
placental blood flow is increased by either a reduction in extrinsic vascular tone (uterine tone) or a 
decrease in intrinsic vascular resistance (placental vasodilatation). 
EFFECTS OF LABOR PAIN ON THE FOETUS
During uterine contractions there is intermittent reduction of the intervillous blood flow and during 
a peak of contraction, there may be a temporary decrease in the placental gas exchange. This is 
worsened by maternal hyperventilation due to severe pain.
 Respiratory alkalosis in the mother results in the following:
• A shift of the mother’s oxygen dissociation curve to the left, diminishing transfer of oxygen 
form mother to the fetus. 
• Maternal hypoxia during uterine relaxation.
• Umbilical vasoconstriction causing a diminution of umbilical blood flow.
• A reduction in uterine blood flow due to elevations in noradrenalin levels.
• Fetal hypoxia
Normally maternal blood receives acid metabolites and carbon dioxide from fetal blood and the 
pH decreases so that there is shift in the maternal oxyhaemoglobin dissociation to the right maintaining 
increased oxygen delivery to the fetus. At the same time in fetal blood, the pH increases leading to a 
shift in fetal oxygen dissociation curve to the left. This effect is known as the double Bohr Effect. In 
prolonged labor maternal hyperventilation leads to alkalosis and with diminishing maternal PaCO2, the 
Bohr Effect may be attenuated and cause hypoxia in conditions of fetal stress. Thus maternal 
hyperventilation as a result of pain decreases fetal oxygenation, presumably by shifting the maternal 
oxygen dissociation curve to the left and by reducing umbilical blood flow.
EFFECTS OF MATERNAL ANALGESIA
Maternal hyperventilation is reduced as a result of adequate pain relief. The periods of 
hyperventilation during contractions followed by hypoventilation during relaxation are avoided and 
PaCO2 remains in the near normal range. Hypoxia consequent to hypoventilation in between 
contraction is also avoided. Epidural analgesia, by blocking impulses as well as sympathetic efferents 
reduces the release of catecholamines, cortisol and ACTH, reducing the stress response.
Analgesia also reduces the marked rise in cardiac output and blood pressure due to pain. These may be 
especially beneficial to the parturient with cardiac disease, PIH and pulmonary hypertension. Maternal 
and fetal acidosis is also reduced.
EFFECTS ON THE FOETUS
The benefits of pain relief, best achieved by regional techniques, are likely to be of value to all infants 
but are especially important to the fetus at risk. Epidural analgesia increases intervillous blood flow by 
vasodilatation and may attenuate the pre-existent vasoconstriction in PIH.
METHODS OF LABOR PAIN RELIEF
A. Non pharmacological Methods:
Psycho prophylaxis
Hypnosis
Aromatherapy
Reflexotherapy
Music and magnets
Breathing Excercises
Acupuncture
TENS
None of the above methods are effective in providing complete pain relief.
B. Pharmacological Methods:
     a.Systemic:
Narcotic analgesia
Sedatives
Ketamine
Inhalational agents-Entonox, Isoflurane, Sevoflurane.
       b.Regional:
Epidural block
Subarachnoid block
Combined spinal –epidural
Lumbar Sympathetic block
Paracervical block
Pudendal block
PHARMACOLOGY OF ROPIVACAINE
GENERIC NAME : Ropivacaine HCl Injection
CHEMICAL NAME S-(-)-1-propyl-2’,6’-pipecoloxylidide hydrochloride monohydrate
PHYSICAL PROPERTIES
The  drug  substance  is  a  white  crystalline  powder,  with  a  chemical  formula  of 
C17H26N2O•HCl•H2O,  molecular  weight  of  328.89.  At  25°C  Ropivacaine  HCl  has  a 
solubility of 53.8 mg/mL (0.164 mol/L) in water, a distribution ratio between n-octanol and 
phosphate buffer at pH 7.4 of 141 and a pKa of 8.07 in 0.1 M KCl solution  12. The pKa of 
Ropivacaine  is  approximately  the  same  as  Bupivacaine  (8.1)  and  is  similar  to  that  of 
mepivacaine  (7.7).  However,  Ropivacaine  has  an  intermediate  degree  of  lipid  solubility 
compared to Bupivacaine and mepivacaine.  The solubility  of Ropivacaine is  limited at  pH 
above 6. Thus, care must be taken as precipitation may occur if Ropivacaine is mixed with 
alkaline solutions.
CHEMICAL PROPERTIES
Ropivacaine HCl Injection is a member of the amino amide class of local anesthetics. It 
is chemically described as S-(-)-1- propyl-2’, 6’-pipecoloxylidide hydrochloride monohydrate . 
Ropivacaine is structurally similar to Bupivacaine and mepivacaine. However, it differs from 
these drugs in that they are racemic preparations, while Ropivacaine is available as the     S-(-) 
enantiomer. The drug substance has a chemical formula of C17H26N2O•HCl•H2O, molecular 
weight of 328.89, and the following structural formula:
STRUCTURAL FORMULA OF ROPIVACAINE
PHARMACOLOGICAL ClASSIFICATION
Ropivacaine HCl Injection is a member of the amino amide class of local anesthetics. It 
is a homologue of Bupivacaine and mepivacaine. Systemic absorption of local anesthetics can 
produce effects on the central nervous and cardiovascular systems. At blood concentrations 
achieved with therapeutic  doses,  changes  in  cardiac  conduction,  excitability,  refractoriness, 
contractility,  and  peripheral  vascular  resistance  are  minimal.  However,  toxic  blood 
concentrations depress cardiac conduction and excitability, which may lead to atrioventricular 
block,  ventricular  arrhythmias,  and  to  cardiac  arrest,  sometimes  resulting  in  fatalities.  In 
addition, myocardial contractility is depressed and peripheral vasodilation occurs, leading to 
decreased cardiac output and arterial blood pressure 21, 22, 23, 24, 26 . Following systemic absorption, 
local anesthetics can produce central nervous system stimulation, depression, or both. Apparent 
central stimulation is usually manifested as restlessness, tremors, and shivering, progressing to 
convulsions,  followed by  depression  and coma,  progressing ultimately  to  respiratory  arrest 
24,25,26. 
Mechanism of action 
Ropivacaine is a member of the amino amide class of local anesthetics and  is supplied as the 
pure  S-(-)-enantiomer.  Local  anesthetics  block  the  generation  and the  conduction  of  nerve 
impulses, presumably by increasing the threshold for electrical excitation in the nerve, slowing 
the propagation of the nerve impulse, and reducing the rate of rise of the action potential.
PHARMACOKINETICS
Elimination: The kidney is the main excretory organ for most local anesthetic metabolites. 
In  total,  86%  of  the  Ropivacaine  dose  is  excreted  in  the  urine  after  intravenous 
administration, of which only 1% relates to unchanged drug
PHARMACOLOGY OF SUFENTANIL
Generic Name : Sufentanil citrate.
Chemical Name      : N-[4-(methoxymethyl)-1-(2-thiopen-2-
ylethyl)-4 -  
  piperidyl] - N – phenyl - propanamide 
Chemical Formula : C22H30N2O2S
Sufentanil, a Synthetic opioid of phenyl piperidine derivative is   5 - 10 times more potent 
than fentanyl with µ agonistic action.
Physical Properties : Mol. weight   - 386.552 gm/mol
  Melting point – 97ºC (207ºF)
  pH     - 3.5-6.0
Preparations : Sufentanil citrate 0.05 mg/ml in
  Preservative free acqueous solution.
Pharmacodynamics:
Cardiovascular System:
- Infrequent Bradycardia
- Preservation of Myocardial Oxygen balance
- At higher doses, 25 µg/kg it attenuates the sympathetic response.
- Infrequent hypotension and that too transient period.
This transient decrease in MAP is occasionally been accompanied by short lasting reduction 
in cerebral perfusion pressure.
Respiratory System:
- Dose dependent respiratory depression due to direct action on medullary 
respiratory centre.
- Hypoxic drive decreased.
- Delayed Respiratory depression can occur even during the postoperative period.
Respiratory depression can be nullified by the opioid antagonist naloxone.
Central Nervous system:
- Hypnosis and anesthesia can be produced at 8µg/kg dosage.
- Adequate reduction in intracranial volume at doses of 20µg/kg in craniotomy 
patients.
- EEG shows decreased cerebral blood flow and cerebral O2 utilization.
Endocrine System:
Attenuation of Sympathetic hormones mainly Noradrenaline .
Pharmacokinetics:
Pharmacokinetics studied using three compartment models.
Distribution time - 0.72 min.
Redistribution time - 13.7 min.
Half Life - 265 min.
Elimination half life - 148 min.
Biotransformation - Liver and small intestine.
Metabolic pathway - O-Oxidative demethylation and N- dealkylation
Plasma protein binding - 93 ± 1%.
Clearance - 12.7 ± 2.5 ml/min/kg.
Volume distribution - 1.7 ± 0.6 lit/kg.
Excretion - 2 - 6% unchanged in urine.
  80% excreted within 24hours.
Epidural and Intrathecal Sufentanil:
Mechanism of action: Spinal opioid µ1 receptor agonist.
Sufentanil  can  be  used  epidurally  for  postoperative  and  labor  analgesia.  Following 
epidural Sufentanil, peak plasma concentration is attained in 10 min and is 4 – 6 times lower 
than  those  of  IV  administration.  Peak  concentration  in  CSF  attains  within  5-90  min  after 
epidural injection. Decay of Sufentanil in CSF is biphasic with an average terminal half life of 
165 min compared to 265 min in plasma. Placental transfer occurs with fetal concentration far 
below maternal plasma concentration but equilibrates rapidly.
Side Effects:
- Nausea/Vomiting
- Pruritis
- Hypotension
- Respiratory depression
- Urinary retention
- Motor blockade
- Chest wall rigidity
REVIEW OF LITERATURE
1.  Levin A et al, Anesth Analg. 1998 Sep: 87(3): 624 -7
The authors did a study comparing two doses of intrathecal Ropivacaine and Sufentanil for 
combined Spinal – Epidural analgesia in parturients. Ropivacaine and it produces less motor 
block  in  equi  -  analgesic  doses  than  Bupivacaine.  They  compared  two  different  doses  of 
intrathecal Ropivacaine (2mg Ropivacaine with 10µg sufentanil) with a standard dose of 2.5 
mg intrathecal Bupivacaine 10µg sufentanil. They concluded that Ropivacaine when combined 
with sufentanil intrathecally is effective for providing CSE labor analgesia but offers no added 
advantage over Bupivacaine in the studied doses.
2. Soni AK, et al, Can I Anesth 2001 Jul - Aug; 4-8 (7) 677-680.
      The authors evaluated the motor sparing effects of low dose Ropivacaine with or 
without sufentanil. 36 term parturients were randomly assigned to receive 3mg of intrathecal 
Ropivacaine or 3mg of intrathecal Ropivacaine with 10µg of sufentanil by CSE technique. 
Patients were evaluated for hypotension, linear analogue score for labor pain, motor power, 
sensory level,  duration of analgesia and neonatal  Apgar scores.  The following day patients 
were assessed for satisfaction, headache and neurologic deficit.
The mean duration of analgesia was 41.4 ± 4.9 min and 95.0 ± 6.1 min for Ropivacaine and 
Ropivacaine with sufentanil respectively. No other significant difference was made out.
They concluded “Low dose Ropivacaine provides effective analgesia during labor via the 
intrathecal  route.  It  can  be  mixed  with  sufentanil  to  improve  the  quality  and  duration  of 
analgesia. Fetal outcome remains favourable. It may provide minimal or no motor block, to 
facilitate ambulation”.
3. McClellan KJ et al, Drugs. 2000 Nov; 60(5):1065-93.
     Ropivacaine: An update of its use in regional anaesthesia.
Ropivacaine  is  a  long  acting,  enantiomerically  pure  (  S  –  enantiomer)  amide  local 
anaesthetic with a high pKa  and low lipid solubility which blocks nerve fibres involved in pain 
transmission  (A  –  delta  and  C  –  fibres)  to  a  greater  degree  than  those  controlling  motor 
function ( A- beta fibers) . The drug was less cardiotoxic than equal concentrations of racemic 
Bupivacaine but more so than lignocaine and had a significantly higher threshold for CNS 
toxicity than racemic Bupivacaine in healthy volunteers. Extensive clinical data have shown 
that epidural Ropivacaine 0.2% is effective for initiation and maintenance of labor analgesia 
and provides excellent postoperative pain relief following abdominal and orthopaedic surgeries. 
In  conclusion,  Ropivacaine,  a  well  tolerated  regional  anaesthetic  with  an  efficacy  broadly 
similar to that of Bupivacaine has reduced CNS and cardiotoxic potential with lower propensity 
for motor block.  
4. Malinovsky JM et al, Anesth Analg. 2000 Dec; 91(6):1457-60.
Intrathecal anaesthesia: Ropivacaine versus Bupivacaine.
The authors compared intrathecal Ropivacaine to Bupivacaine in patients scheduled for 
TURP Surgeries. They have chosen in a ratio of 3:2 potency of isobaric Ropivacaine (15mg) 
and isobaric Bupivacaine (10mg) in 100 patients and tested for sensory level, motor blockade 
and  hemodynamic  effects.  They  concluded  that  15  mg Ropivacaine  intrathecally  provided 
similar motor and hemodynamic effects but less potent anaesthesia than 10 mg of intrathecal 
Bupivacaine for endoscopic urological surgeries.
5.  Van Kleef JW et al, Anesth Analg 1998:87:624-7.
Spinal anaesthesia with Ropivacaine.
The authors did a double blind study on the efficacy and safety of 0.5% and 0.75% 
Ropivacaine (3ml) in patients undergoing minor lower limb and lower abdominal surgeries. 
They concluded that less intense motor block and lesser duration of motor block with 0.5% 
Ropivacaine and equated the anaesthetic properties of 0.75% Ropivacaine with those of 0.5% 
Bupivacaine
6. Malinovsky et al Anesthesiology Aug 2002; 97(2): 429-35.
The authors did a study in experimental models regarding the relationship between doses of 
intrathecal  Ropivacaine  and  side  effects  and  local  neurotoxic  effects.  Seven  days  after 
intrathecal injections, Spinal cord and nerves were sampled for histopathology. In conclusion, 
Ropivacaine induced dose dependent spinal anaesthesia produce no neurotoxicologic lesion in 
experimental models.
7. McNamee et al, BJA 2002; 89(5): 702 – 6.
The  authors  did  a  prospective  double  blind  study  in  patients  undergoing  Total  hip 
Replacement surgeries. They concluded that Ropivacaine produces less intense motor block 
and less duration of motor block, thus establishing the motor sparing effect of Ropivacaine.
8.  Camorcia M et al, Anesth Analg 2004 Jun; 98(6): 1779 – 82.
     The authors did the study in patients undergoing elective LSCS using various dilutions of 
intrathecal local anaesthetic solutions determine less motor block and this may be considered in 
ambulant laboring patients.
9. Viscomi CM, Rathmell JP, Pace NL; Anesth Analg 1998 Jan; 86(1): 219- 20.
  The  authors  did  a  prospective  cohort  observational  study  comparing  the  duration  of 
intrathecal labor analgesia after intrathecal injections made in early labor (3-5 cm cervical 
dilatation) and  those made in more advanced labor (7-10 cm cervical dilatation). Forty one 
parturients (18 in early labor and 23 in advanced labor) received intrathecal sufentanil (10 
micro grams) and Bupivacaine (2.5 mg) as part of a combined spinal – epidural technique. 
They found the duration of spinal analgesia was significantly less when intrathecal injection 
was made in advanced labor (120 ± 26 min) compared with early labor  (163 ± 57 min), P < 
0.01. They concluded that cervical dilatation and stage of labor significantly impact the 
effective duration of intrathecal Bupivacaine/ sufentanil labor analgesia.
10. Dresner M et al, BJA 2000; 85: 826 - 9.
Did a study comparing 0.2% Ropivacaine with 2µg/ml Fentanyl and 0.1% Bupivacaine with 
2µg/ml Fentanyl for CSE. They found Ropivacaine group was more likely to be pain free in the 
first  stage  (51%  Vs  33.7%;  p  =0.01).  There  were  no  significant  differences  in  patients 
assessment of motor block or mode of delivery between the groups. Pain relief and patient 
satisfaction were better in Ropivacaine group but did not reach statistical significance.
11. Sia AT et al, Can J Anesth.1998 Jul; 45: 620 – 5.
The  authors  compared  the  combination  of  intrathecal  sufentanil  with  Bupivacaine  and 
intrathecal sufentanil alone for labor analgesia and found that adding Bupivacaine resulted in 
higher  incidence of  hypotension,  reduced ability  to ambulate  and higher sensory  blockade. 
They  decided  that  quality  of  analgesia  was  excellent  even  without  Bupivacaine  and 
Bupivacaine resulted in higher side effects.
 
12. Camann WR et al, Anesthesiology – 1992 Nov; 77(5): 884 – 7.  
A  Comparison of intrathecal, epidural and intravenous sufentanil for labor analgesia.
Twenty four women in active labor were divided into 3 group receiving sufentanil either 
intrathecally,  epidurally  or  intravenously  using  combined  spinal  –  epidural  analgesia.  In 
conclusion, the duration of analgesia was significantly prolonged in intrathecal route (1-2 hrs) 
than epidurally (mean 30 mins) or intravenously (mean 34 min).  Also the intrathecal route 
showed rapid and significant decrease in visual analogue scale scores. However the side effects 
were limited to pruritis only.
13. Campbell DC et al, Anesth Analg. 1995 Aug; 81(2): 305 - 9.
The addition of local anaesthetic, Bupivacaine to intrathecal sufentanil for labor analgesia.
      Fifty two parturients were taken and allocated to three groups to receive either 2.5 mg 
Bupivacaine or 10 microgram sufentanil or 2.5 mg Bupivacaine with 10 micro gram sufentanil. 
In  conclusion,  the  quality  and  duration  of  labor  analgesia  were  much  superior  in  the 
Bupivacaine with sufentanil group. Thus addition of 2.5 mg Bupivacaine prolongs the duration 
of labor analgesia without any adverse maternal or fetal effects.
14. Sia AT et Al, Anesth Analg 1999 Feb; 88(2): 362- 6.
Combination of intrathecal sufentanil 10 micro gram plus Bupivacaine 2.5 mg for labor 
analgesia: Is half the dose enough?
The author compared two different doses of intrathecal sufentanil 10 µg and 5 µg with 
Bupivacaine  2.5 mg for  labor  analgesia  using combined spinal  –  epidural  technique.  They 
concluded that half the recommended dose of 10 µg of sufentanil with Bupivacaine 2.5 mg 
adequately relieves the labor pain. However they added further that the larger dose produced 
faster pain relief which was long lasting than the reduced dose without adversely affecting the 
maternal and fetal outcome.
15. Savoia G et al, Minerva Anesthesiol. 2001 Sep; 67(9 Suppl 1): 206-16.
The  authors  evaluated  relevant  trials  on  perioperative  sufentanil  in  order  to  design  an 
optimal strategy for administration. 24 Trials were found eligible. It was possible to compare 
the use of IV and epidural sufentanil alone or in combination with local anaesthetics, clonidine, 
Ketamine and adrenaline. They concluded “Efficacy of sufentanil resulted the same or better 
than other  analgesics  used commonly despite  context  –  sensitive  half  –  life  advantage.  Its 
association with local anaesthetics or other adjuvant drugs prolong its action and sometimes 
decreases the side effect. Sufentanil can be used at very low doses with local anaesthetics or 
adjuvant drugs via epidural, intravenous or intrathecal route for perioperative analgesia”.
16.  Nelson KE et al, Anesthesiology. 2002 May; 96(5): 1070 – 3.
The authors  made a  comparative  study on intrathecal  sufentanil  and Fentanyl  for  labor 
analgesia  using  CSE  technique.  They  concluded  that  the  relative  potency  of  intrathecal 
sufentanil  to  Fentanyl  for  labor  analgesia  is  4.4:  1  and the  duration of  analgesia  was  also 
significantly prolonged with the sufentanil group without any statistically significant difference 
in the side effects between the two.
       
17. Pickering et al, Anesthesiology 1999; 91: 436 - 41.
The author  performed computerized posturographic  testing on 44 women in  labor  after 
institution  of  regional  analgesia  and  compared  them with  a  control  group  of  44  pregnant 
women.  The authors  were  unable  to  find  any functional  impairment  of  balance  after  CSE 
ambulatory analgesia in women in labor who had no clinical evidence of motor block.
18. D’ Angelo R et al, Anesth Analg. 1999 Mar; 88: 573 – 6.
Studied the effects of spinal clonidine in prolonging CSE duration using Bupivacaine and 
sufentanil.  Analgesia  was  significantly  prolonged  in  the  clonidine  added  group.  They 
concluded that spinal clonidine significantly prolongs labor analgesia from spinal sufentanil 
and Bupivacaine without producing serious adverse side effects.
19. Landau R et al, Semin Perinatol. 2002 Apr; 26: 109 – 21.
     The authors reviewed various studies comparing Epidural and CSE. They concluded “CSE 
should  be  considered  a  major  breakthrough  in  the  management  of  labor  analgesia”.  The 
advantages of CSE include more rapid onset, reduced total drug dosage, minimal or no motor 
blockade and increased patient  satisfaction.  CSE has  also been associated with more rapid 
cervical dilatation when compared to epidural analgesia in nulliparous women in early labor.
20. Kartawiadi L et al, Reg Anesth. 1996 May- Jun; 21: 191 - 6.
Conducted a comparative study in 63 laboring parturients between  epidural group (0.125% 
Bupivacaine,  10  µg sufentanil,  12.5 µg epinephrine  –  10ml  doses)  and   CSE using  1  mg 
Bupivacaine , 5µg sufentanil and 25µg epinephrine. CSE provided longer analgesia, more rapid 
onset and better satisfaction.
21. Rawal N et al, Anesthesiol clin N. America 2000 Jan; 18:267-9.
Concluded that CSE technique by  ‘needle through needle technique ‘resulted in better 
epidural catheter siting. He also concluded that the concern about epidural catheter entering 
through the small dural hole was unfounded.
22. Calimaran AL et al, Anesth Analg 2003 Apr; 96:1167-72.
The authors conducted a study to test  the effect  of standard epidural  test  dose (3ml 
lignocaine 1.5% with epinephrine 1:200000) on motor block in CSE labor analgesia.  They 
concluded that a standard lignocaine epidural test dose injected immediately after initiating 
combined spinal  epidural  labor  analgesia with Bupivacaine  2.5mg and Fentanyl  25µg may 
interfere with the ability to perform simple test of motor function and ambulation.
MATERIALS AND METHODOLOGY
This is a prospective randomized controlled study. Prior approval was obtained from the 
ethics  committee  of  STANLEY MEDICAL  COLLEGE  AND HOSPITAL  and  RSRM 
Lying –in hospital for the study. Forty parturients who were admitted to the labor ward and 
who  requested  pain  relief  during  labor  were  selected  for  the  study.  The  procedure  was 
explained to them in detail and written consent was obtained from them.
Inclusion Criteria:
1. Patients in early active labor (Cervical dilatation 3-5 cms) 9
2. Patients belonging to ASA I.
3. Only primigravida patients with singleton pregnancy were included in the study.
4. Vertex presentation.
Exclusion Criteria:
1. Patients with medical or systemic disorders.
2. Patients with obstetric complications (PIH, GDM, Eclampsia, etc.)
3. Presentation other than vertex
4. Any contraindications for Central Neuraxial Blockade.
5. Patients who have already received parenteral opioids or systemic analgesics.
6. Patients with known allergy to local anaesthetics.
The patients were randomly divided into two groups of twenty each.
Group R (Ropivacaine):
Received  3mg  Ropivacaine  0.2  %(  1.5ml)  intrathecally  followed  by  epidural  drugs 
(0.0625% Bupivacaine with Fentanyl 1.5 µg/ml) as 10ml top-ups, during the entire period of 
labor. The top-ups were given only when the patient requested for additional pain relief. 
Group RS (Ropivacaine with Sufentanil):
Received  3mg Ropivacaine  0.2% (1.5ml)  along with  Sufentanil  as  preservative  free 
solution 10µg (0.2ml) intrathecally, followed by epidural top-ups as 10ml solutions(0.0625% 
Bupivacaine with Fentanyl 1.5 µg/ml).
Since the study period ended when the patient requested for further analgesia by epidural 
route after initial intrathecal injection, both the groups received same drugs via the epidural 
route  for  the  purpose of  standardization.  A standard epidural  test  dose  itself  will  result  in 
augmentation of motor blockade31. Further, the addition of epinephrine to confirm intravascular 
placement is not reliable in active labor. Hence the test doses were put away with, rather the 
first bolus dose was given in two divided doses with 5 mins interval. 
The procedure was clearly explained to the patient. The visual analog scale was shown 
to them and interpretation of the scale explained in detail.  The patients were shifted to the 
operation theatre for performing CSE technique in aseptic manner.
Anaesthesia  machine  was  checked  and  all  emergency  airway  equipments  like 
Laryngoscopes, different blades of different sizes, endotracheal   tubes of appropriate sizes, 
LMAs, oropharyngeal airways were kept ready. An emergency drug tray containing all  the 
emergency drugs was also kept ready.
IV access was secured with an 18G venflon. All patients included in the study were 
preloaded with 10ml/kg of Lactated Ringer’s solution. Patient’s vital parameters like heart rate, 
blood pressure, SPO2, respiratory rate, and fetal heart rate were continuously monitored during 
the procedure. The baseline values were recorded. The drugs to be administered intrathecally 
were prepared and stored in a sterile container.
Equipments:
The needles used for both groups were 17G Tuohy needle,19G epidural catheter and 
26G pencil point long spinal needle (CSE cure by Portex).
Procedure:
With the patient in left lateral position, under strict aseptic precaution L2-3 interspace 
was identified and skin infiltration was done with 1.5 ml of 2% lignocaine. Using 17G Tuhoy 
needle, epidural space identified by ‘loss of resistance to air’ technique.
Intrathecal  injection  was  performed  using  long  spinal  needle  (pencil  point  26G 
Whitacare) through epidural needle (needle through needle technique)32 at rate of 0.2ml per 
second. Immediately following this, 19G epidural catheter was inserted and kept 3cms inside 
the epidural space. The catheter was secured firmly to the back. The patient was turned to 
supine position. Epidural drugs were not given till patients first request for analgesia.
With catheter in place, patients were shifted to labor ward after 20 mins of observation 
in operation theatre, where they were closely monitored till delivery. A single operator was 
involved in all cases and intravenous/intrathecal placement of  epidural catheter was ruled out 
by  aspiration for blood /CSF.
The study period commenced with the intrathecal injection and ended at the patients first 
request for analgesia.
The following parameters were observed:
1. HR,BP,SPO2,Respiratory rate at 0,5,10,15,30,45,60,90 and 120 mins.
2. Time of onset of analgesia – time of intrathecal injection to patients perception of first 
painless contraction..
3. Level of sensory blockade with loss of sensation to cold using surgical spirit.
4. Motor blockade by modified Bromage scale.
Grade Level of motor blockade Clinical assessment
0 Nil Free movement of legs and feet
1 Partial Just able to flex the  knees , free 
movements of feet
2 Almost complete Unable to flex knees , free movements of 
feet possible
3 Complete Unable to move both legs and feet
5. Duration of analgesia – defined between commencement of intrathecal injection  to the 
patients first request for analgesia.      
6. Visual analog pain scale (VAS)
7. Hourly cervical dilatation
8. Mode of delivery, duration of labor
9. Fetal  heart  rate  and APGAR at 1 and 5 mins.
10. Patient comfort, satisfaction 
[4- Excellent, 3 – Good, 2 –Fair, 1- poor]
11. Side effects –Hypotension, nausea/vomiting, pruritis, respiratory depression, urinary 
retention, etc.
The  patients  were  informed  to  ask  for  additional  pain  relief  even  when they  felt  mild 
discomfort / pain. The routine obstetric practice was allowed to continue. In our institution, 
injection Oxytocin infusion was used to accelerate labor. Artificial rupture of membranes done 
if  indicated  .During  the  entire  labor,  patients  were  positioned  supine  with  left  side  tilt. 
Ambulation was allowed after assessing their motor power. The following tests were done in 
sequence to assess their motor power.
Straight leg raising
Sit at edge of cot unsupported.
Stand for a minute without support.
Perform a deep knee bend test.
Take three unassisted steps.
RESULTS
The study was conducted in Government RSRM  Lying-in Hospital during 2006. 
Forty patients in active labour (Cervical dilatation 3-5 cms)9 who requested analgesia were 
chosen and randomly assigned to either of the two groups :
R-Group (Ropivacaine) :  Recieved intrathecal Ropivacaine 3mg as part of CSE, 
followed by epidural top-ups with bupivacaine 0.0625% and fentanyl 1.5µg/ml.
RS-Group (Ropivacaine with Sufentanil) : Recieved intrathecal Ropivacaine 3mg 
with  Sufentanil  10  µg  as  part  of  CSE,  followed  by epidural  top-ups  with  bupivacaine 
0.0625% and fentanyl 1.5µg/ml for standardization.
The study commenced at the intrathecal injection and completed with the patients 
first request for analgesia. The above stated period alone was taken for statistical analysis, 
using students  t-test, Chi-Square tests, fischer tests. Since some of the cases end earlier, 
the datas were taken for analysis upto 45 mins duration, though all the parameters were 
monitored till the delivery of the baby.
Demographic Profile and Obstetric Parameters
R-Group
(mean ± S.D)
RS-Group
(mean ± S.D)
P- Value
AGE(years) 21.75 ± 2.31 21.9 ± 2.17 0.83
HEIGHT(cms) 156.55 ± 4.65 157.4 ± 2.98 0.49
WEIGHT(kgs) 59.0 ± 2.83 60.10 ±  4.02 0.32
GEST-AGE(wks) 39.05 ± 0.69 38.75 ± 0.72 0.18
CERV-DIL(cms) 3.92 ± 0.72 3.92 ± 0.72 1.00
The  physical  characteristics  like  Age,  Height,  Weight,  Gestational  age,  Cervical 
dilatations were compared between the two groups. For all the above parameters, the p-
value >0.05 (not significant)
VAS Score
Time
(min)
R-Group
(mean ± S.D)
RS-Group
(mean ± S.D)
T-Test
P- Value
0 7.7 ± 0.57 7.75 ± 0.64 > 0.05
5 2.35 ± 0.49 2.45 ± 0.51 > 0.05
10 1.2 ± 0.41 1.3 ± 0.46 > 0.05
15 1.15 ±  0.37 1.05  ±  0.22 > 0.05
30 2.5 ± 1.24 1.00 ± 0.00 0.000
45 3.79  ±  1.25 2.7  ±  0.57 0.000
The visual analog scale for pain scoring was taken over the period of time. P-value 
using student T-test was not significant until 15 mins, but differs statistically significant by 
30 mins onwards implying prolonged duration of analgesia in the RS-group.
Onset of Analgesia
R-Group
(mean ± S.D)(mins)
RS – Group
(mean ± S.D)(mins)
P. Value
2.45 ± 0.51 2.7 ± 0.57 0.153
The onset of analgesia between the groups was not statistically significant.
Sensory Level
Group 5min 10min 15min 30min 45 min
R – Group (median) T9 T8 T8 T9 T10
RS – Group (median) T9-10 T8 T8 T8 T8
The median sensory level over the period of time was tabulated above for both the 
groups.  The  descend  of  sensory  level  in  the  R-group  by  30  and
 45 min showed shorter duration than in the RS-group.
Motor Level
The motor level by modified Bromage scale showed nil motor blockade in both the 
groups over various time period which was not statistically significant.
Duration of Analgesia
R-Group
(mean ± S.D) (min)
RS – Group
(mean ± S.D) (min)
P. Value
47.6 ±  10.04 93.25 ±  10.72 0.000
The duration of analgesia was statistically significant (P-0.000) with RS-group 93.25 
± 10.72 min over R- group 47.6  ± 10.04 min.
Duration of Labor
I Stage II Stage III Stage Total Duration
R-Group
(mean±S.D)(mins)
189.75  ± 
22.45
54.5 ± 9.61 14.45 ± 2.86 258.7 ± 29.7
R-Group
(mean±S.D)(mins)
192.75  ± 
26.92
52.65 ± 5.76 14.85 ± 2.96 260.25 ± 28.12
P – Value 0.704 0.465 0.666 0.866
They show no statistical significance using the T- test.
Hemodynamic variables
Systolic Blood Pressure :
Time
(min)
R-Group
(mean±S.D)(mmHg)
RS-Group
(mean±S.D)(mmHg)
P- Value
T-Test
0 125.4 ± 4.36 126.5 ± 5.35 0.480
5 115.7 ± 4.65 117.2 ± 4.37 0.300
10 112.8 ± 4.51 112.0 ± 4.21 0.565
15 112.7 ±  5.08 111.9  ±  4.52 0.602
30 116.8 ± 5.75 112.0 ± 4.21 0.005
45 124.29  ±  5.92 114.7  ±  4.60 0.000
The systolic  pressure showed statistical  significance only by 30 min and 45 min 
again due to regression of sensory level in the R-group.
Diastolic Blood Pressure :
Time
 
R-Group
(mean±S.D)(mmHg)
RS-Group
(mean±S.D)(mmHg)
P- Value
T-Test
0 80.9 ± 4.61 81.6 ± 4.19 0.618
5 75.5 ± 3.83 77.4 ± 4.68 0.168
10 73.1 ± 3.34 74.3 ±  4.27 0.328
15 73.6 ±  3.82 73.9  ±  3.75 0.803
30 78.5 ± 4.98 74.8 ± 4.37 0.017
45 83.14 ±  3.74 75.2 ±  3.69 0.000
Again  by  30  min  and  45  min,  the  diastolic  blood  Pressure  showed  statistical 
significance due to regression of sensory level in R-group.
Maternal Heart Rate :
Time
 
R-Group
(mean±S.D)(bpm)
RS-Group
(mean±S.D)(bpm)
P- Value
T-Test
0 106.05 ± 8.76 106.85  ± 10.29 >0.05
5 88.85 ± 5.32 89.0 ± 4.13 >0.05
10 80.65 ± 5.62 81.65 ±  3.12 >0.05
15 78.3 ±  5.51 78.75  ±  3.56 >0.05
30 83.65 ± 7.66 79.15 ± 5.16 <0.05
45 89.64 ±  7.01 78.55 ±  6.24 <0.05
The heart rate between the groups varied significantly by 30 min and 45 min.
Fetal Heart Rate :
Time
 
R-Group
(mean±S.D)(bpm)
RS-Group
(mean±S.D)(bpm)
P- Value
T-Test
0 151.25 ± 11.18 151.95  ± 10.6 0.840
5 146.8 ± 7.45 145.95 ± 5.49 0.684
10 146.45 ± 8.86 145.4 ±  7.63 0.130
15 149.45 ±  7.78 142.3 ±  7.05 0.004
30 152.9 ± 8.60 149.3 ± 8.85 0.200
45 152.64 ±  6.76 148.95 ±  6.68 0.124
             Though, the fetal heart rate was not statistically significant between the groups 
except at 15 min, it was well within the acceptable range of fetal heart rate of 120-160 beats 
per minute.
Fetal outcome
R-Group
(mean ± S.D)
RS-Group
(mean ± S.D)
P- Value
T-Test
APGAR 1 6.85 ± 0.37 6.8  ± 0.41
0.687
APGAR 5 9.00 ± 0.00 8.95 ± 0.22
0.330
No statistical significance in the APGAR score between the groups at 1 min and 5 
min.
Number of Epidural top-ups
R-Group
(mean ± S.D) (Min)
RS – Group
(mean ± S.D) (Min)
P. Value
T-Test
3.60 ±  0.68 2.55 ±  0.60 0.000
The number of epidural top-ups showed statistical significance as the duration of analgesia 
in the RS-group is prolonged causing less analgesic requirements. 
Comfort scale
Poor Fair Good Excellent
R-Group 0 1 8 11
RS-Group 0 1 9 10
Chi-Square value = 0.948
Almost all the parturients were very much satisfied with the pain relief measures.
Complications
RS – Group
(n)
RS – Group
(n)
Hypotension 0 0
Nausea / vomiting 0 1
Pruritis 0 2
Urinary Retention 3 3
PDPH 0 0
Resp. Depression 0 0
Sedation 0 0
Other complications 0 0
By applying pearson Chi-square test, no statistical significance of any complications 
occurred between the groups. These complications were only minor and easily managed by 
reassuring the patients.
DISCUSSIONS
A number of methods exist to provide pain relief to the laboring parturients. Among 
all the regional techniques epidural is considered the gold standard for labor analgesia until 
a major breakthrough brought was about by Collins28 and collegues as combined spinal – 
epidural technique.
Most of the parturients  had reported the pain relief was rapid and the quality of 
analgesia was superior. These findings were quite consistently similar in the studies carried 
out by Kartawiadi et al29, van de Velde et al30.
In this study, I compared a mixture of intrathecal Ropivacaine and Sufentanil with 
Ropivacaine alone. Ropivacaine was physically compatible with Sufentanil.  When  used 
alone,  intrathecal  Ropivacaine  provided shorter  duration  of  analgesia  as  compared to  a 
similar dose mixed with Sufentanil. At this dose, maternal hemodynamic instability was 
minimal and adverse fetal effects were absent.
Ropivacaine  is  a  local  anaesthetic  with  lower  cardiotoxic  potential21,22,23,24,26  and 
higher  threshold  for  neurtoxicological  symptoms24,25,26  than  racemic  bupivacaine.  The 
majority of published data on ropivacaine are on its use in the epidural space (MC Crae et 
al18,  Datta S et al19). There is little data available for its intrathecal use. Various studies 
show that at equal drug concentrations intrathecal Ropivacaine is less potent and produces a 
shorter duration and lesser intensity of motor block15,16,17. Iida et al 23 using an closed spinal 
window technique in a canine model showed that Ropivacaine vasoconstricts, in a dose 
dependent fashion,the pial arterioles and venules as compared to bupivacaine. Kristensen et 
al  24 recently  reported  its  relative safety when using ropivacaine in  a  rat  model.  Using 
clinically  relavant  doses,  they suggested it  can be administered in  the intrathecal  space 
without significantly  lowering the spinal cord blood flow.
 van Kleef  et  al  14 first  reported  its  intrathecal  use  in  patients  undergoing lower 
abdominal surgery by comparing 3 ml of 0.5% Ropivacaine with 0.75% Ropivacaine. They 
found the less intense motor block and lesser duration of block with 0.5% Ropivacaine and 
equated the anaesthetic properties of 0.75% Ropivacaine with those of 0.5% Bupivacaine. 
Levin et al  10, described the use of the small dose of intrathecal Ropivacaine mixed with 
Sufentanil  for labor analgesia.  Comparing it  with a bupivacaine sufentanil  mixture they 
found no difference in the duration of analgesia, side effects and motor block. 
In our study, the onset of analgesia was no indifferent between the two groups (2.45 
mins ± 0.5 in the R-group vs 2.70 mins ± 0.57 in the RS-group). The duration of analgesia 
in the RS-group was significantly prolonged than  the R-Group (mean 93.25 mins ± 10.72 
mins  and  mean  47.60  mins  ± 10.04  mins  respectively)  showing  the  additive  effect  of 
intrathecal Sufentanil for labor analgesia1,2,3,4,11 The VAS score was also compared and the 
mean VAS score at 30 min and 45 min were found to be statistically significant which was 
well  correlated  with the duration of  analgesia  between the  two groups,  as  the  R-group 
patients started feeling discomfort and pain, with request for first  analgesic  dose much 
earlier than the RS-group patients.
The  sensory  level  between  the  two  groups  taken  as  median  showed  significant 
difference only by 30 mins onwards as the R-group patients requested for the first analgesic 
dose earlier than the RS-group again correlating with the difference in duration of analgesia 
between the two groups. When compared to R-group, more number of patients in the RS-
group reached a sensory level of T6 (7 in RS-group vs 5 in R-group) over various period of 
time. The difference in volumes between the two groups may have influenced the level of 
sensory blockade, but it seems unlikely. Using equidose hyperbaric and isobaric intrathecal 
bupivacaine, Malinovsky et al 27, reported that volume had no significant influence on either 
cephalad spread or duration of sensory blockade.
In both the groups, the motor blockade by modified Bromage scale was nil and at any 
time, all the patients could be able to do the SLR test.  This signifies the motor sparing 
effect of Ropivacaine15,16,17.
Regarding  the  hemodynamic  parameters,  no  patients  in  both  the  groups  had 
significant fall in BP (both systolic and diastolic) after the initiation of intrathecal labor 
analgesia upto 30 mins. There was a statistical difference in the hemodynamic parameters 
by 30 and 45 mins which was secondary to the prolonged  pain relief in the RS-group8.
The duration of labour in both the groups were no indifferent and the fetal outcome 
was also favourable in both the groups by comparing the APGAR at 1 and 5 mins between 
the groups. The fetal heart rate was statistically significant by 15 mins between the two 
groups(mean 149.45±7.78bpm in R-group vs mean 142.3±7.05bpm in RS-group) but was 
well within the acceptable range of 120-160 beats per minute7.
With regard to the mode of delivery,  only one patient  in the R-group underwent 
LSCS. The indication  for  which was persistent  occipito  transverse lie,  not  of  any fetal 
distress or others. Anaesthesia was provided using the epidural catheter. All others in the 
study delivered by labor natural with episiotomy.
The  number  of  epidural  top-ups  between  the  two  groups  showed  statistical 
significance (mean 3.60  ± 0.68 in R- group vs mean 2.5  ± 0.60 in the RS-group) thus 
implying  the  lesser  analgesic  requirement  in  the  RS-group  which  may  be  considered 
advantageous.
Regarding the  complications,  no  patients  had  significant  hypotension  in  both  the 
groups. Two patients had pruritis 5,6 one patient had nausea and vomiting (one episode) in 
the RS-group and three patients in each group had urinary retention. Just reassurance was 
more than sufficient in all these cases. No patients had PDPH in both the groups.
During the follow-up period, no patients developed any neurological complications 
in  both  the  groups.  Regarding the  patient  comfort,  almost  all  patients  showed  good to 
excellent in their satisfaction except one who had the scale of fair.
Roux et al  33 and others have indicated that CSE was technically difficult and were 
not able to place the epidural catheter after intrathecal drug placement.  In our study, no 
such difficulty  was  encountered.  There  were  no  incidence  of  intravenous  or  intrathecal 
catheter placement. 
SUMMARY
In my study, parturients in both the groups had effective pain relief and gave more 
satisfaction  because  of  the  earlier  onset  of  analgesia  thus  Ropivacaine,  a  useful  local 
anaesthetic in labor analgesia.
Motor blockade was nil in both the groups, making Ropivacaine, an effective drug in 
central neuraxial analgesia, especially in settings where ambulation should be retained, such 
as analgesia during labor or outpatient anaesthesia.
The duration of  analgesia was prolonged(mean 93.25 mins in RS-group vs mean 
47.6 mins in R-group) when sufentanil is added intrathecally as an additive providing better 
pain relief, although no statistical difference between the groups in patients satisfaction.
Maternal and fetal outcomes were also favourable.
Complications were only few, minor and easily manageable with just reassurance. 
The technique doesnot pose any additional difficulty. 
CONCLUSION
In my study, I conclude low dose intrathecal Ropivacaine(3 mg as 0.2% solution) 
provides  effective  and rapid   pain  relief  ,and  doesnot  impair  the  motor  function.  Thus 
ambulation is made easy in CSE labour analgesia, without imposing any significant impact 
on the hemodynamics, mode of delivery, duration of labor or fetal outcome. Hence low 
dose intrathecal Ropivacaine is a safe drug in CSE labor analgesia. And when combined 
with sufentanil the quality and  duration of intrathecal analgesia is much better(almost twice 
the duration) with minimal side effects.
Low dose  intrathecal  Ropivacaine  with  Sufentanil  provides  safe  and  satisfactory 
labor analgesia and can be used in all parturients who request labor pain relief. 
  Providing pain relief to laboring parturients will surely be a gratifying experience 
for the anaesthesiologists.
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Identification:
       Name: Age: I.P.No:   Unit:
Preop Assessment:
ASA:      Vitals: PR -      BP-       FHR-      VAS-     Cervix:      Presenting part:
Events:
Start of procedure (skin infiltration): Pain free contraction:
Epidural catheter placement: VAS<1:
Intrathecal drug administration:  I stage:
End of procedure (Pt placed supine):              II stage:
Onset of sensory loss:              Time of delivery:
Variable Basal   0 
min
 2 
min
  5 
min
 10 
min
  15 
min
 30 
min
  45 
min
  60 
min
90 
min
120 
min
180 
min
PR
BP
VAS
Sensory 
level
Bromage 
scale
FHR
Cervix
Epidural Topups
Time Total
Volum
e
Obstetric Intervention:
Oxytocin acceleration - Membrane rupture- other drugs:
Delivery   - LN   / LN with epi   / Instrumental   / Caesarian
Total duration of labor (I+II stage):  
Baby Apgar: 1 min-     5min-        
Patient Comfort – Excellent   / good   / fair   / poor   
Side effects: - Hypotension   / Bradycardia   / Nausea   / Vomiting   / Shivering   / Pruritus   / Resp dep 
/ Urinary retention   / others 
